Literature DB >> 19333690

Takayasu disease on the centenary of its discovery.

Kazuhisa Sugiyama1,2, Shigeyuki Ijiri3, Shigeki Tagawa3, Koichi Shimizu4.   

Abstract

Takayasu disease was first reported in 1908 by Mikito Takayasu as "a case of peculiar changes in the central retinal vessels." Because in these patients the pulse of the radial artery is impalpable, investigations focusing on the ischemic symptoms of the upper body were conducted. In 1948, Shimizu and Sano named this pathological condition "pulseless disease." Since then, the lesions of Takayasu disease have been detected not only in the aortic arch and its main branches but also in various vessels, including the abdominal aorta and renal arteries. The ocular symptoms of Takayasu disease are considered to be due to ischemia in the retina and choroid. The typical wreath-like arteriovenous anastomosis around the disc reported by Takayasu is observed at a relatively late stage of the disease. The characteristic fundus findings of Takayasu disease include tortuosity and dilatation of the central retinal artery and vein, retinal arteriovenous anastomosis, prominent retinal vasculature, microaneurysms in the capillaries, occlusion of retinal arterioles, soft exudate, choked disc, and optic atrophy. Fluorescein angiography reveals retinal microaneurysms, sludging, slower blood flow, dilatation of retinal vessels, leakage of fluorescence dye due to increased vascular permeability, and arteriovenous anastomosis. Arteriovenous anastomosis initially appears in the periphery at the early stage, and in the arteriovenous crossing at the advanced stage. Systemic administration of corticosteroids is required to prevent vascular stenosis during the early stages of Takayasu disease. Reconstruction of the carotid artery may improve subjective symptoms and fundus findings.

Entities:  

Mesh:

Year:  2009        PMID: 19333690     DOI: 10.1007/s10384-009-0650-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  65 in total

1.  Scleritis as a presenting feature of Takayasu's disease.

Authors:  R Jain; A Ionides; C Pavesio; A Russell; D Haskard
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

2.  PULSELESS DISEASE.

Authors:  I S JAIN; A D GROVER
Journal:  Br J Ophthalmol       Date:  1963-05       Impact factor: 4.638

3.  Pathology of pulseless disease. A systematic study and critical review of twenty-one autopsy cases reported in Japan.

Authors:  T NASU
Journal:  Angiology       Date:  1963-05       Impact factor: 3.619

4.  [A case of posterior ischemic optic neuropathy associated with pulseless disease].

Authors:  M Kiyosawa; T Asano
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1982

5.  Importance of fluorescein angiographic study in evaluating early retinal changes in Takayasu disease.

Authors:  T Baba; K Itakura; R Tanaka; T Kawasaki; M Kiyosawa; F Numano
Journal:  Jpn J Ophthalmol       Date:  1999 Nov-Dec       Impact factor: 2.447

6.  Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate.

Authors:  Fumiko Tanaka; Atsushi Kawakami; Nozomi Iwanaga; Mami Tamai; Yasumori Izumi; Kouichiro Aratake; Kazuhiko Arima; Makoto Kamachi; Hideki Nakamura; Mingguo Huang; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Journal:  Intern Med       Date:  2006-04-03       Impact factor: 1.271

7.  Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.

Authors:  Gary S Hoffman; Peter A Merkel; Richard D Brasington; Deborah J Lenschow; Patrick Liang
Journal:  Arthritis Rheum       Date:  2004-07

8.  [Takayasu disease--pulseless disease].

Authors:  Keiji Sano
Journal:  Brain Nerve       Date:  2008-01

9.  Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis.

Authors:  Masahiro Endo; Yasuko Tomizawa; Hiroshi Nishida; Shigeyuki Aomi; Makoto Nakazawa; Yukio Tsurumi; Masatoshi Kawana; Hiroshi Kasanuki
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

10.  Unilateral hemorrhagic keratouveitis as the initial presentation of Takayasu's arteritis.

Authors:  Subashini Kaliaperumal; Arvind Gupta; Sabyasachi Sengupta; Renuka Srinivasan
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

View more
  5 in total

Review 1.  Is Takayasu arteritis the result of a Mycobacterium tuberculosis infection? The use of TNF inhibitors may be the proof-of-concept to demonstrate that this association is epiphenomenal.

Authors:  Diana Castillo-Martínez; Luis M Amezcua-Castillo; Julio Granados; Carlos Pineda; Luis M Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2020-03-20       Impact factor: 2.980

2.  The Role of Echocardiography in Evaluation of Takayasu's Arteritis: A Report of Two Cases.

Authors:  Aman Patel; Subrahmanya Murti Velamakanni; Rinal M Parikh; Sapan Pandya; Tejas Patel
Journal:  Cureus       Date:  2021-05-28

Review 3.  New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory.

Authors:  J Luis Espinoza; Suzue Ai; Itaru Matsumura
Journal:  Pathogens       Date:  2018-09-06

4.  A case of anti-VEGF therapy application in Takayasu arteries with retinopathy.

Authors:  Qiaoyun Gong; Tianwei Qian; Feng'e Chen; Xun Xu; Weijun Wang
Journal:  Am J Ophthalmol Case Rep       Date:  2020-04-29

5.  Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.

Authors:  Franco Dammacco; Anna Cirulli; Annalisa Simeone; Patrizia Leone; Raffaele Pulli; Domenico Angiletta; Giuseppe Rubini; Alessandra Di Palo; Angelo Vacca; Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2020-10-07       Impact factor: 3.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.